The European advanced wound care market is mainly driven by technological advances, rising geriatric population, problems associated with ineffective traditional wound healing methods, initiatives taken by the government, and a pressing need for swift and safer treatment of chronic wounds.
According to Diabetes UK, people suffering from Diabetes were around 3.8 million in the year 2018. The increasing incidences of diabetes may further lead to growth in this market. The growing prevalence of several lifestyle disorders leading to chronic wounds, such as diabetic foot ulcer, venous leg ulcer, and pressure ulcer, is one of the key factors estimated to encourage the growth of the advanced wound care market in the coming years.
The statistics from Public Health England (PHE) revealed that there were 27,465 amputations between 2015 and 2018, compared with 24,181 cases between 2012 and 2015 a rise of 14 per cent. Furthermore, attempts to lower the duration of hospital stay, in order to reduce the surgical healthcare expenses, and the growing inclination toward products that enhance therapeutic outcomes are also driving the demand in the advanced wound care market.
However, the high cost associated with the treatment and reimbursement issues for the new technologies remain major factors hindering the market.
Key Market Trends
Under Wound Dressings, Foam Dressings Projected to Have Significant Growth
- Foam dressings are a type of extremely absorbent dressing used for wound care. Foam dressings are used for heavily exuding wounds, like weeping ulcers, deep cavity wounds, and wounds caused after debridement.
- These dressings can be used for a longer duration of time, as they have lower replacement rates when compared to other types of dressings. These are generally made from semi-permeable polyurethane.
- They allow water vapor to enter but keep out contaminants and bacteria. In some cases, the outer layer of these dressings may be waterproof, depending upon the need.
- The launch of new products and advancements in product technologies are projected to fuel market growth. In April 2017, ConvaTec has launched Foam Lite ConvaTec dressing, a light, flexible silicone foam dressing for managing low to non-exuding chronic and acute wounds.
- Moreover, the ability of these dressings to be used as primary or secondary dressings during accidents or other severe cases is also expected to increase their adoption.
The advanced wound care market is significantly fragmented, with the presence of a large number of players. As technology progresses and becomes more viable, the quality of life of patients afflicted with chronic wounds improves. Traditional wound care and closure products are being increasingly substituted with advanced wound care and closure products, due to their efficacy and effectiveness in managing wounds by enabling faster healing. Market players are focusing on various growth strategies, in order to enhance the market presence by mergers, acquisitions, partnerships, collaborations, new product launches, etc.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This report will be delivered within 2 business days.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Chronic Wounds, Ulcers, and Diabetic Ulcers
4.2.2 Increase in Volume of Surgical Procedures
4.2.3 Growing Demand for Faster Recovery of Wounds
4.2.4 Rising Geriatric Population
4.3 Market Restraints
4.3.1 Lack of Proper Reimbursements
4.3.2 High Treatment Costs
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Wound Dressings
220.127.116.11 Film Dressings
18.104.22.168 Foams Dressings
22.214.171.124 Hydrogel Dressings
126.96.36.199 Collagen Dressings
188.8.131.52 Other Dressings
5.1.2 Active Wound Care
184.108.40.206 Skin Substitutes
220.127.116.11 Growth Factors
5.1.3 Therapy Devices
18.104.22.168 Negative Pressure Wound Therapy
22.214.171.124 Pressure Relief Devices
126.96.36.199 Hyperbaric Oxygen Equipment
188.8.131.52 Compression Therapy
184.108.40.206 Other Therapy Devices
5.1.4 Other Advance Wound Care Products
5.2 By Wound Type
5.2.1 Chronic Wound
220.127.116.11 Diabetic Foot Ulcer
18.104.22.168 Pressure Ulcer
22.214.171.124 Arterial and Venous Ulcer
126.96.36.199 Other Chronic Wound
5.2.2 Acute Wound
188.8.131.52 Surgical Wounds
184.108.40.206 Other Acute Wounds
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3M Company
6.1.2 B. Braun Melsungen AG
6.1.3 Cardinal Health Inc.
6.1.4 Coloplast AS
6.1.5 ConvaTec Group PLC
6.1.6 Integra Lifesciences
6.1.7 Molnlycke Health Care
6.1.8 Paul Hartmann AG
6.1.9 Smith & Nephew
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
- 3M Company
- B. Braun Melsungen AG
- Cardinal Health Inc.
- Coloplast AS
- ConvaTec Group PLC
- Integra Lifesciences
- Molnlycke Health Care
- Paul Hartmann AG
- Smith & Nephew